Christopher B. Hopson

Design of amidobenzimidazole STING receptor agonists with systemic activity

Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang et al. · Nature · 2018 · 803 citations

Systemic Activity, Medicine, Mechanism Of Action +4

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Stem Cells · 2008 · 280 citations · Full text

Platelet Numbers, Immunology, Blood Cell +21

Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Experimental Hematology · 2005 · 202 citations · Full text

Thrombopoiesis, Thrombosis, Signal Transduction +9

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra et al. · PLoS ONE · 2018 · 197 citations · Full text

Unique Tumor-immune Infiltrate, Novel Anti-cancer Immunotherapies, Immunology +17

Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of Megakaryocytopoiesis

Kevin J. Duffy, Michael G. Darcy, Evelyne Delorme et al. · Journal of Medicinal Chemistry · 2001 · 119 citations · Full text

Drug Target, Molecular Biology, Pharmacotherapy +17